KX2-391 10mg 10mg | Purity Not Available
Adooq Bioscience
KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
More Information Supplier PageKX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageLY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageGSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, respectively.
More Information Supplier PageGSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, respectively.
More Information Supplier PageKX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
More Information Supplier PageKX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
More Information Supplier Page